Julie Harney

Company: Pfizer

Job title: Senior Principal Scientist

Seminars:

Spotlighting Lessons Learned from Validating & Implementing Organoids to De-Risk Oncology Therapeutic Development 11:30 am

Discussing the need to build robust protocols to enhance model reproducibility and empower their validation Employing techniques to characterize organoid and ensure reproducibility and translatability for safety studies Assessing the applications of organoids for safety considerations to de-risk therapeutic candidates before moving to patientsRead more

day: Day 2

Advancing the Comparability of Functional Assay Data to Better Validate 3D Tissue Models 12:00 pm

With more pharma companies than ever before evaluating the potential of 3D tissue models for drug development, it’s critical that the industry overcomes the key challenge of validating that these models are physiologically relevant and can produce data to match up to in vivo models to instil confidence in the read-outs they generate. Functional assays…Read more

day: Pre-Conference Day